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Increasing antimicrobial resistant and the lack of new antibiotics poses a major public threat. Furthermore, 
conventional medical devices fail to avoid microbial colonization resulting in healthcare associated infections. 
These threats have triggered the search for new antimicrobial materials that have the ability to kill 
microorganisms in a general way and, especially considering those directed for medical devices, without 
damaging human tissues. With advances in synthetic biology approaches, it is now possible to reengineer novel 
functionalities and structures of protein-based materials, taking advantage of their extreme versatility and 
applicability. By combining the antimicrobial activity of naturally occurring antimicrobial peptides (AMPs) with 
recombinant protein-based polymers (rPBP), it is possible to create novel materials that can be explored for the 
development of advanced antimicrobial medical devices. 
In this work we have constructed a novel antimicrobial rPBP by combining a synthetic cationic AMP fused in 
frame with an elastin-like recombinamer consisting of 200 repeats of the structural unit VPAVG, for improved 
biocompatibility and processing. The new polymer construction, named CM4-A200, was biologically produced 
in Escherichia coli and purified by exploring the thermoresponsiveness property of poly-VPAVG.  
The antimicrobial activity of the hybrid polymer CM4-A200 was studied in the form of free standing films 
produced by solvent casting, especially thinking in downstream processing for application as thin film coating of 
medical devices. The CM4-A200 films showed high growth inhibition against a wide range of bacterial species, 
both Gram positive and negative as well as against fungi. The antimicrobial activity proved to be time-
dependent, by direct contact and, in the case of A. nidulans, was inclusively inhibitor of spore germination. 
Remarkably, in some cases, almost 100% of cell death was detected after 30 minutes of contact with the cast 
films. Furthermore, we demonstrate that cell death is a consequence of irreversible cell damaging and disruption. 
Finally, we describe the development of an ex vivo assay using pig skin, that avoids the use of glued components 
that may interfere with antimicrobial activity. Ex vivo assays in pig skin sustained the high antimicrobial activity 
of this material, whereas no cytotoxic effect was found for a normal human fibroblast cell line.  
These results significantly support the potential of this genetically engineered polymer for application as 
antimicrobial medical devices or coatings, representing a major breakthrough in the development of protein-
based materials and demonstrates the high versatility of these materials. 
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Bacterial colonisation of indwelling devices remains a serious threat in clinical field as it is commonly associated 
to persistent infections, called biomaterial-associated infections (BAI). Pseudomonas aeruginosa is the most 
common gram-negative bacillus associated with BAI and its emergence as a nosocomial pathogen is a growing 
concern. This opportunistic pathogen can produce a capsule-like polysaccharide called alginate that contributes 
to mucoid biofilm structure and persistent nature of infections. Given alginate's  contribution to bacterial 
virulence, it has long been considered  as a promising target for interventional therapies. Alginate lyase, an 
enzyme able to degrade alginate, has been shown to detach mucoid biofilms from abiotic surfaces and increase 
their antibiotic susceptibility.  
In this work, a new approach for alginate lyase was explored.  Instead of using this enzyme for the treatment of 
pre-established mucoid biofilms, the ability of alginate lyase to prevent P. aeruginosa adhesion to a surface was 
investigated. For that purpose, a polydopamine (pDA) dip-coating strategy was applied for functionalization of 
biomaterials with alginate lyase. Polycarbonate (PC) substrates were immersed in an alkaline solution of 
dopamine to form a thin layer of pDA and then transferred into a solution of alginate lyase. Surface 
characterization was performed with XPS, contact angle measurement and SEM. Two reference strains of P.
aeruginosa, a mucoid strain (ATCC 39324) and a non-mucoid (27853) as well as four clinical isolates, were used 
to assess the anti-adhesive properties of the functional coatings.  
Surface characterization confirmed the successful and efficient grafting of alginate lyase onto pDA-coated PC 
substrates. Untreated PC substrates allowed the adhesion of both reference strains and most of bacteria were 
found alive on these surfaces. Polydopamine-coated substrates had no significant effect on bacterial adhesion 
compared to the unmodified substrates. Substrates functionalized with alginate lyase exhibited anti-adhesive 
properties, causing a significant inhibition of the mucoid strain adhesion. Interestingly, substrates immobilized 
with this enzyme also proved to inhibit the adhesion of the non-mucoid strain and pDA-coated PC substrates 
immobilized with heat-inactivated enzyme also prevented the attachment of both bacterial strains. These results 
suggested that alginate lyase immobilized on pDA-coated substrates was able to impair P. aeruginosa
adhesion regardless its mucoid phenotype and therefore it could be applied in a different context than 
cystic fibrosis. For instance, this enzyme could be used to develop functional coatings able to prevent P.
aeruginosa infections associated to biomaterials. To confirm this hypothesis, the attachment of 4 
clinical strains of P. aeruginosa, isolated from peritoneal dialysis catheters, on alginate lyase functional 
coatings were also evaluated. Alginate lyase immobilized on the substrates impaired the attachment of 
the clinical strains with the exception of one as its adhesion to the unmodified PC was already low.  
In this work, the versatile chemistry of polydopamine was successfully exploited to functionalize biomaterial 
surfaces with alginate lyase to impart them with anti-adhesive properties. The antibacterial performance of these 
alginate functional coatings was catalysis-independent which highlights the importance of further studies to 
better understand its mechanism of action against P. aeruginosa strains.
Acknowledgements: The authors thank the project FCT PTDC/SAU-SAP/113196/2009/FCOMP-01-0124-FEDER-016012, 
the Strategic Project PEst-OE/EQB/LA0023/2013, the Project “BioHealth - Biotechnology and Bioengineering approaches 
to improve health quality", Ref. NORTE-07-0124-FEDER-000027, co-funded by the Programa Operacional Regional do 
Norte (ON.2 – O Novo Norte), QREN, FEDER, the project “RECI/BBB-EBI/0179/2012 - Consolidating Research Expertise 
and Resources on Cellular and Molecular Biotechnology at CEB/IBB”, Ref. FCOMP-01-0124-FEDER-027462, FEDER. 
The authors also acknowledge Diana Alves PhD Grant SFRH/BD/78063/2011. Authors also acknowledge Dr. Margarida 
Martins for kindly provided the isolated strains which were obtained under the scope of the project "Insights into peritoneal 
dialysis catheter associated biofilms" funded from the Portuguese Society of Nephrology to Dr. Anabela Rodrigues.  
Keywords alginate lyase; antibacterial coating, Pseudomonas aeruginosa; biomaterial-associated infections
III International Conference on Antimicrobial Research - ICAR2014
247
Madrid (Spain), 1-3 October 2014
